Kolexia
Gervais Radj
Pneumologie
Centre François-Baclesse
Caen, France
207 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Métastase tumorale Carcinomes Récidive tumorale locale Tumeurs du cerveau Adénocarcinome Anaphylaxie

Industries

AstraZeneca
11 collaboration(s)
Dernière en 2023
MSD
9 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
6 collaboration(s)
Dernière en 2023
Pfizer
5 collaboration(s)
Dernière en 2023

Dernières activités

MELROSE: Phase 2 Study Evaluating MEchanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtinib Until and Beyond Radiological Progression : the MELROSE Trial
Essai Clinique (AstraZeneca)   26 février 2024
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study.
Lung cancer (Amsterdam, Netherlands)   22 septembre 2023
Increased creatinine levels, around a case of onco-nephrology.
Nephrologie & therapeutique   20 juin 2023
Endoscopic resection of tracheal and bronchial granular cell tumours: A national multicentre retrospective study.
Respirology (Carlton, Vic.)   10 juin 2023
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial.
ESMO open   06 juin 2023
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   19 mai 2023
NEOCARDIO: Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
Essai Clinique (Hôpital Pitie Salpetriere)   20 avril 2023
MAPS: A Phase II-III Randomized Trial Pemetrexed-Cisplatin Chemotherapy With or Without Bevacizumab (Avastin), 15 mg/kg, for Malignant Pleural Mesothelioma (MPM)
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   10 mars 2023
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Scientific reports   03 mars 2023
Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab.
BMC cancer   09 janvier 2023